196 related articles for article (PubMed ID: 14616997)
1. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.
Chessells JM; Veys P; Kempski H; Henley P; Leiper A; Webb D; Hann IM
Br J Haematol; 2003 Nov; 123(3):396-405. PubMed ID: 14616997
[TBL] [Abstract][Full Text] [Related]
2. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
Chessells JM; Bailey C; Wheeler K; Richards SM
Lancet; 1992 Sep; 340(8819):565-8. PubMed ID: 1355153
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
[TBL] [Abstract][Full Text] [Related]
6. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Tallen G; Ratei R; Mann G; Kaspers G; Niggli F; Karachunsky A; Ebell W; Escherich G; Schrappe M; Klingebiel T; Fengler R; Henze G; von Stackelberg A
J Clin Oncol; 2010 May; 28(14):2339-47. PubMed ID: 20385996
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
Wheeler K; Richards S; Bailey C; Chessells J
Br J Haematol; 1998 Apr; 101(1):94-103. PubMed ID: 9576189
[TBL] [Abstract][Full Text] [Related]
10. A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results.
Chessells JM; Leiper AD; Richards SM
Br J Haematol; 1994 Jan; 86(1):48-54. PubMed ID: 8011547
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
Lancet; 1995 Sep; 346(8979):873-6. PubMed ID: 7564672
[TBL] [Abstract][Full Text] [Related]
12. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases.
Frassoni F; Barrett AJ; Grañena A; Ernst P; Garthon G; Kolb HJ; Prentice HG; Vernant JP; Zwaan FE; Gratwohl A
Br J Haematol; 1988 Nov; 70(3):317-20. PubMed ID: 3061443
[TBL] [Abstract][Full Text] [Related]
13. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
Borgmann A; Baumgarten E; Schmid H; Dopfer R; Ebell W; Göbel U; Niethammer D; Gadner H; Henze G
Bone Marrow Transplant; 1997 Dec; 20(11):939-44. PubMed ID: 9422472
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Uderzo C; Valsecchi MG; Balduzzi A; Dini G; Miniero R; Locatelli F; Rondelli R; Pession A; Arcese W; Bacigalupo A; Polchi P; Andolina M; Messina C; Conter V; Aricó M; Galimberti S; Masera G
Br J Haematol; 1997 Feb; 96(2):387-94. PubMed ID: 9029031
[TBL] [Abstract][Full Text] [Related]
16. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
[TBL] [Abstract][Full Text] [Related]
17. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
Chybicka A; Bogusławska-Jaworska J; Gorczyńska E; Juszczak K; Armata J; Balcerska A; Balwierz W; Bubała H; Filiks-Litwin B; Kołecki P; Kowalczyk J; Lukowska K; Matysiak M; Rokicka-Milewska R; Rola-Kurc E; Stencel D; Sońta-Jakimczyk D; Strojny W; Wachowiak J; Wieczorek M; Wysocki M; Zelenay E
Wiad Lek; 1998; 51 Suppl 4():25-32. PubMed ID: 10731940
[TBL] [Abstract][Full Text] [Related]
19. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.
Oskarsson T; Söderhäll S; Arvidson J; Forestier E; Montgomery S; Bottai M; Lausen B; Carlsen N; Hellebostad M; Lähteenmäki P; Saarinen-Pihkala UM; Jónsson ÓG; Heyman M;
Haematologica; 2016 Jan; 101(1):68-76. PubMed ID: 26494838
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee.
Zhang MJ; Hoelzer D; Horowitz MM; Gale RP; Messerer D; Klein JP; Löffler H; Sobocinski KA; Thiel E; Weisdorf DJ
Ann Intern Med; 1995 Sep; 123(6):428-31. PubMed ID: 7639442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]